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ABSTRACT
Objective: The objective of this study was to investigate the influence of gender and obesity on analgesic modulation of tramadol in Wistar rats.
Methods: This study was carried out in two sets of experiments. In Set I experiment - 48 rats (body weight ≤150 g), 24 each male and female rats were 
randomly divided into two groups (n=6/group) (Group I - Control; 0.9% NaCl; 1 ml/kg/day i.p. and Group II - Tramadol 10 mg/kg/day i.p.) for each 
nociception model - plantar test and acetic acid-induced writhing test. The treatment duration was of 5 days. On the last day of treatment (i.e., on the 
5th day), paw withdrawal latency (PWL) was assessed using plantar test, and writhing movements were observed following administration of 0.8% 
acetic acid; 10 ml/kg i.p. Set II experiment was repeated like Set I experiment among rest 48 high-fat diet-fed rats (body weight ≥300 g).
Results: For both males and females, PWL was significantly decreased (p<0.05) in obese control groups compared to lean control groups. A number of 
writhing movements were significantly increased (p<0.01 for males and p<0.001 for females) in obese control groups compared to lean control groups. 
In tramadol-treated obese rats, PWL was significantly decreased (p<0.01 for males and p<0.05 for females), and number of writhing movements were 
significantly increased (p<0.01 for both males and females) in comparison with the tramadol-treated lean rats.
Conclusion: The present study revealed that obese female rats experience more pain sensation to noxious stimuli compared to lean male rats and also 
the analgesic effect of tramadol is more pronounced in lean male rats compared to obese female rats.
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INTRODUCTION
According to the International Association for the Study of Pain 
(IASP), pain is an unpleasant sensory and emotional experience 
arising from actual or potential tissue damage or described in terms 
of such damage [1]. Sex differences in pain and its control have long 
been a debated issue for scientists and health-care providers hoping 
to optimize pain treatment for the individual. The current scenario 
toward evidence-based medicine has further highlighted this issue. In 
the year 2007, the sex, gender, and pain special interest group of the 
IASP issued a consensus paper highlighting the need for inclusion of 
both males and females in pre-clinical and clinical studies on pain and 
its management [2]. In one of the randomized clinical trials, females 
have been shown to experience greater intensity of post-operative pain 
and less tolerance to pain compared to men [3].
Rosseland and Stubhaug stated gender difference in response to opioids, 
but their findings are inconsistent [4]. Some studies suggest that female 
patients experience greater analgesic efficacy compared to males following 
administration of mixed opioid agonist-antagonists, whereas other studies 
with morphine demonstrate that women require a higher drug dose 
compared to males to achieve analgesia of the same degree [3-5].
Several studies have positively correlated the experience of pain with 
an increase in body mass index (BMI) [6,7]. The causal relationship 
between the two remains unclear: It is not known whether obesity 
causes chronic pain, chronic pain causes obesity, or some other factors 
cause both concurrently. Obesity is hypothesized to lead to pain because 
of excess mechanical stresses and its proinflammatory state.
Obesity can affect pain threshold, emotional mood, and quality of 
life. Differences in pain thresholds and emotional mood may have 
implications for pain and depression management. Differences in pain 
thresholds may have implications for pain management, as they may 
account in part for the variability in analgesic requirements between 
individuals. In obese patients, pain thresholds would make it possible 
to predict the need for prescriptions of drugs with a narrow therapeutic 
margin, such as morphine [8]. McKendall and Haier conducted a study 
based on the hypothesis claiming that analgesic opiates are increased 
in obesity [9]. They applied a constant pressure of approximately three 
pounds to the tip of the thumb on 56 obese and non-obese patients to 
measure the time interval until the first sensation of pain. However, 
contrary to the expectations, the obese patients were found to be more 
sensitive to pain. Roane and Porter used tail pinch or tail flick pain 
stimulation tests and found that Zucker rats were more sensitive to 
pain [10].
There is need for further studies to investigate the influence of gender 
and obesity on pain threshold and analgesic modulation of opioids. This 
might help to modify the practice of prescribing analgesic medication 
according to gender and BMI. Tramadol is a synthetic, centrally acting 
analgesic agent with two distinct, synergistic mechanisms of action, and 
acting as both a weak opioid agonist and an inhibitor of monoamine 
neurotransmitter reuptake [11]. Earlier, we had reported the analgesic 
modulation of some analgesics in male and female Wistar rats [12]. 
Consequently, the aim of the present study was to investigate the effect 
of tramadol on pain threshold among male and female Wistar rats using 




Active pharmaceutical ingredient of tramadol was obtained from 
Sigma-Aldrich, Bangalore (India). Acetic acid and other chemicals 
were purchased from Merck Life Sciences Pvt. Ltd., Mumbai (India). 
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Normal saline (0.9% Sodium chloride) was purchased from pharmacy 
of Kasturba Hospital, Manipal, Karnataka (India).
Animals
A total of 96 Wistar rats (48 each male and female) weighing 100–
150 g were housed in separate polypropylene cages, maintained 
under standard conditions with temperature (22–24°C), 12-h 
light/12-h dark cycle, and relative air humidity 40–60%. The animals 
were acclimatized to the laboratory conditions for 1 week before the 
start of the experiment. The animals were provided with a normal 
pellet diet (Amrit Feeds Ltd., Pune, India) and water ad libitum. The 
experimental protocol was approved by the institutional animal ethics 
committee (IAEC/KMC/41/2014), and experiments were conducted 
according to the ethical norms approved by Ministry of Social Justice 
and Empowerment, Government of India and Committee for the 
Purpose of Control and Supervision on Experiments on Animals 
guidelines.
Experimental design
A total of 96 Wistar rats were included in this study. The study was 
carried out in two sets of experiments. In Set I experiment - 48 lean rats 
(body weight 100–150 g), 24 each male and female rats were randomly 
divided into two groups (n=6/group) (Group I - control; 0.9% NaCl; 
1 ml/kg/day i.p. and Group II - tramadol 10 mg/kg/day i.p.) for each 
nociception model - plantar test and acetic acid-induced writhing test 
(Fig. 1). Set II experiment was repeated like Set I experiment among 
rest 48 high-fat diet-fed (Vanaspati dalda + Coconut oil; 3:1; 10 ml/kg/
day for 90 days) obese rats (body weight ≥300 g) (Fig. 2). The treatment 
duration of this study was 5 days. On the last day of treatment (i.e., on 
the 5th day), 15 min after administration of normal saline/tramadol, 
paw withdrawal latency (PWL) was assessed using plantar test, and 
writhing movements were observed following administration of 0.8% 
acetic acid; 10 ml/kg i.p [12-14].
High-fat diet-induced obesity model
For Set II experiment, 48 Wistar rats (100–150 g, 24 males and 
24 females) were housed as two rats/cage. In addition to the normal 
pellet diet, these animals were orally fed mixture of Vanaspati dalda 
+ Coconut oil (3:1) - 10 ml/kg/day for 90 days. After 90 days, these 
rats attained body weight approximately ≥300 g. Thereafter, Set II 
experiment was repeated like Set I experiment on these 48 obese (body 
weight ≥300 g).
Nociception models
Plantar test (Hargreaves’ method)
Thermal pain threshold to radiant heat (IR-90) was quantified using the 
paw withdrawal test (Fig. 3). Rats were placed in a Perspex enclosure, 
without restraint and a movable infrared radiant heat source placed 
directly under the plantar surface of the hind paw (Ugo Basile, Como, 
Italy). The PWL to radiant heat was defined as the time from onset 
of the radiant heat to the withdrawal of the rat hind paw. The cutoff 
time for PWL was 30 s. Testing was alternated between hind paws and 
carried out at 3 min intervals. The average of three estimations was 
taken to yield mean PWL. Before any testing was carried out, rats could 
adjust to their environments for at least 10 min.
Acetic acid-induced writhing test
Writhing movement was induced by administering an intraperitoneal 
injection of 0.8% acetic acid (10 ml/kg), 15 min after the tramadol/
normal saline administration. After 10 min of acetic acid administration, 
the number of writhing movements such as abdominal constriction/
elongation of body/arching of back/hind limb extension/forelimb 
extension/trunk twisting (Fig. 4) was cumulatively counted over 20 
min further for nociceptive evaluation [12-14].
Statistical analysis
Using Statistical Package for the Social Sciences (SPSS version 16.0; 
SPSS Inc., Chicago, USA), data were expressed as mean ± standard 
deviation and analyzed by one-way analysis of variance followed by 
post hoc Tukey test. A level for p≤0.05 was considered as statistically 
significant.
Fig. 1: Experimental design for lean Wistar rats (Set-I 
experiment)
Fig. 2: Experimental design for obese Wistar rats (Set-II 
experiment)
Fig. 3: Hargreaves apparatus for plantar test
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RESULTS
For both lean and obese rats, PWL was significantly decreased (p<0.001) 
and number of writhing movements were significantly increased 
(p<0.001) in female control groups compared to male control groups. 
Furthermore, in tramadol-treated female rats, PWL was significantly 
decreased (p<0.01 for lean and p<0.05 for obese groups) and number 
of writhing movements were significantly increased (p<0.001 for both 
lean and obese groups) in comparison with the tramadol-treated male 
rats (Figs. 5 and 6).
For both males and females, PWL was significantly decreased (p<0.05) 
in obese control groups compared to lean control groups. Number of 
writhing movements were significantly increased (p<0.01 for males 
and p<0.001 for females) in obese control groups compared to lean 
control groups. In tramadol-treated obese rats, PWL was significantly 
decreased (p<0.01 for males and p<0.05 for females) and number of 
writhing movements were significantly increased (p<0.01 for both 
males and females) in comparison with the tramadol-treated lean rats 
(Figs. 7 and 8).
DISCUSSION
The present study has demonstrated the influence of gender and obesity 
on analgesic modulation of tramadol in Wistar rats using plantar test 
and acetic acid-induced writhing test. This study has revealed the 
lower pain threshold in obese female rats than the lean male rats. In 
experimentally induced pain studies, the majority of results show that 
women are comparatively less tolerant and more sensitive to noxious 
stimulation than men [15-17]. Sex-related differences in pain may also 
reflect differences in the endogenous opioid system. The most studied 
of the endogenous pain modulatory systems is the endogenous opioid 
system, and sex differences in the functioning of this system could 
arise based on several different mechanisms. First, sex differences 
could result from differences in the distribution, expression, or 
sensitivity of opioid receptors in regions of the central nervous system 
involved in nociceptive processing. Sex-specific differences in gonadal 
hormones, genetic factors, central nervous system pain and pain 
Fig. 4: Acetic acid-induced writhing movements
Fig. 5: Overall, comparison of paw withdrawal latency among both 
lean and obese male and female rats. n=6, number of rats in each 
group; NC: Normal control; TRM: Tramadol. Values are mentioned 
as mean. Error bars, ±2 standard deviation
Fig. 6: Overall, comparison of number of writhing movements 
among both lean and obese male and female rats. n=6, number 
of rats in each group; NC: Normal control; TRM: Tramadol. Values 
are mentioned as mean. Error bars, ±2 standard deviation
Fig. 7: Comparative analysis of paw withdrawal latency for lean 
versus obese rats. n=6, number of rats in each group; NC: Normal 
control; TRM: Tramadol. Values are mentioned as mean. Error 
bars, ±2 standard deviation
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modulation circuitry, pharmacokinetic/pharmacodynamic factors, 
and psychosocial factors have been advanced as potential mechanisms 
for sex differences in opioid analgesia. Jomo et al. suggests that there 
are many possible molecular mechanisms through which estrogen 
might diminish orphanin FQ (OFQ)-induced antinociception, including 
decreasing the expression of the (opioid receptor-like-1) ORL1 receptor 
and/or its coupling to G-proteins which would secondarily modify the 
affinity of OFQ to the ORL1 receptor [18]. Reciprocally, the requirement 
for testosterone in mediating the antinociceptive effects of OFQ in the 
male could be attributable to upregulating expression of the ORL1 
gene or enhancing coupling of OFQ receptors to (Gi/Go) proteins and 
thus to downstream effectors [18]. Kepler et al. suggests that including 
gender as an independent variable, morphine does not produce the 
same degree of antinociception in male and female, especially following 
the induction of persistent pain [19]. Dahan et al. suggests that 
animal studies show a tendency for opioids to act more efficaciously 
in male, human studies are less clear in the presence and direction 
of any sex effect [20]. According to Palmeira et al., the differences in 
pain perception related to sex may be associated with hyperalgesia in 
women but also to the hypoactivity of the inhibitory system of pain 
in females [21]. In a prospective observational study on 120 patients 
(60 males and 60 females), conducted by Hussain et al., reported that 
female patients exhibited greater intensity of pain and required higher 
doses of analgesics compared to males in the immediate post-operative 
period to achieve a similar degree of analgesia [22].
Endocrine changes during the obesity may be responsible for the 
difference in the pain threshold. Leptin is a peptide (146 amino 
acid - long protein encoded by the obesity [ob] gene) secreted by 
adipose cells that act as a major regulator for food intake and energy 
homeostasis. Recent studies have shown that leptin, an adipocytokine, 
played a significant role in nociceptive behavior induced by nerve injury 
in rats [23,24]. Maeda et al. reported that the peripheral effect of leptin 
on neuropathic pain is mediated via macrophage stimulation [24]. 
Whereas, central effect of leptin on neuropathic pain is possibly due to 
the up-regulation of N-methyl-d-aspartate (NMDA) receptors following 
nerve injury [23]. This could be the reason for more pain in obese rats.
CONCLUSION
The present study revealed that obese female rats experience more 
pain sensation to noxious stimuli compared to lean male rats and also 
the analgesic effect of tramadol is more pronounced in lean male rats 
compared to obese female rats. Additional research to elucidate the 
mechanisms driving sex differences and obesity in pain responses is 
needed to foster future interventions to reduce these disparities in pain 
and analgesic modulation of tramadol. Henceforth, we are carrying out 
this study further on molecular level to find out the possible correlation 
among sex hormones, obesity, pain threshold, and tramadol. Gender 
and body mass index specific tailoring of pain treatments may become 
a conceivable outcome in the foreseeable future.
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